Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Short

Showing results (161-170 of 203) with videos related to

Pageof 21
Sort By:
Clinical Oncology (Royal College of Radiologists (Great Britain))|February 26, 2023
Re-irradiation: From Cell Lines to Patients, Filling the (Science) Gap in the MarketL J Murray, A L Appelt, T Ajithkumar, et al.
Neuroscience|November 11, 2020
Ring Finger Protein 11 (RNF11) Modulates Dopamine Release in DrosophilaEve Privman Champaloux, Nathan Donelson, Poojan Pyakurel, et al.
BMC Cancer|October 8, 2016
Amino-acid PET versus MRI guided re-irradiation in patients with recurrent glioblastoma multiforme (GLIAA) - protocol of a randomized phase II trial (NOA 10/ARO 2013-1)Oliver Oehlke, Michael Mix, Erika Graf, et al.
Clinical and Experimental Immunology|December 1, 2019
Expression profiling of single cells and patient cohorts identifies multiple immunosuppressive pathways and an altered NK cell phenotype in glioblastomaH J Close, L F Stead, J Nsengimana, et al.
Neuro-Oncology Advances|July 10, 2020
Hydroxychloroquine and short-course radiotherapy in elderly patients with newly diagnosed high-grade glioma: a randomized phase II trialLucy Brazil, Angela L Swampillai, Ka Man Mak, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 19, 2016
ESTRO-ACROP guideline "target delineation of glioblastomas"Maximilian Niyazi, Michael Brada, Anthony J Chalmers, et al.
International Journal of Cancer|June 12, 2014
Loss of expression of the tumour suppressor gene AIMP3 predicts survival following radiotherapy in muscle-invasive bladder cancerPratik M S Gurung, Abhi Veerakumarasivam, Magali Williamson, et al.
BMC Cancer|April 14, 2022
HOX and PBX gene dysregulation as a therapeutic target in glioblastoma multiformeEinthavy Arunachalam, William Rogers, Guy R Simpson, et al.
Neuro-Oncology|October 31, 2021
Prevalence of BRAFV600 in glioma and use of BRAF Inhibitors in patients with BRAFV600 mutation-positive glioma: systematic reviewLily J Andrews, Zak A Thornton, Saanwalshah S Saincher, et al.
Oncotarget|May 18, 2016
NOTCH blockade combined with radiation therapy and temozolomide prolongs survival of orthotopic glioblastomaSanaz Yahyanejad, Henry King, Venus Sosa Iglesias, et al.
Pageof 21

Showing results (161-170 of 203) with videos related to

Sort By:
Pageof 21
Clinical Oncology (Royal College of Radiologists (Great Britain))|February 26, 2023
Re-irradiation: From Cell Lines to Patients, Filling the (Science) Gap in the MarketL J Murray, A L Appelt, T Ajithkumar, et al.
Neuroscience|November 11, 2020
Ring Finger Protein 11 (RNF11) Modulates Dopamine Release in DrosophilaEve Privman Champaloux, Nathan Donelson, Poojan Pyakurel, et al.
BMC Cancer|October 8, 2016
Amino-acid PET versus MRI guided re-irradiation in patients with recurrent glioblastoma multiforme (GLIAA) - protocol of a randomized phase II trial (NOA 10/ARO 2013-1)Oliver Oehlke, Michael Mix, Erika Graf, et al.
Clinical and Experimental Immunology|December 1, 2019
Expression profiling of single cells and patient cohorts identifies multiple immunosuppressive pathways and an altered NK cell phenotype in glioblastomaH J Close, L F Stead, J Nsengimana, et al.
Neuro-Oncology Advances|July 10, 2020
Hydroxychloroquine and short-course radiotherapy in elderly patients with newly diagnosed high-grade glioma: a randomized phase II trialLucy Brazil, Angela L Swampillai, Ka Man Mak, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 19, 2016
ESTRO-ACROP guideline "target delineation of glioblastomas"Maximilian Niyazi, Michael Brada, Anthony J Chalmers, et al.
International Journal of Cancer|June 12, 2014
Loss of expression of the tumour suppressor gene AIMP3 predicts survival following radiotherapy in muscle-invasive bladder cancerPratik M S Gurung, Abhi Veerakumarasivam, Magali Williamson, et al.
BMC Cancer|April 14, 2022
HOX and PBX gene dysregulation as a therapeutic target in glioblastoma multiformeEinthavy Arunachalam, William Rogers, Guy R Simpson, et al.
Neuro-Oncology|October 31, 2021
Prevalence of BRAFV600 in glioma and use of BRAF Inhibitors in patients with BRAFV600 mutation-positive glioma: systematic reviewLily J Andrews, Zak A Thornton, Saanwalshah S Saincher, et al.
Oncotarget|May 18, 2016
NOTCH blockade combined with radiation therapy and temozolomide prolongs survival of orthotopic glioblastomaSanaz Yahyanejad, Henry King, Venus Sosa Iglesias, et al.
Pageof 21